112 related articles for article (PubMed ID: 8235695)
1. Interferon in the treatment of chronic myeloid leukemia. Proceedings of a workshop. February 4-7, 1993, Flims, Switzerland.
Semin Hematol; 1993 Jul; 30(3 Suppl 3):1-54. PubMed ID: 8235695
[No Abstract] [Full Text] [Related]
2. [The treatment of chronic myeloid leukemia in chronic phase with interferons].
Guilhot F
Pathol Biol (Paris); 1988 Dec; 36(10):1179-81. PubMed ID: 3070457
[No Abstract] [Full Text] [Related]
3. Juvenile chronic myeloid leukaemia and alpha-interferon.
Aricò M; Nespoli L; Caselli D; Bonetti F; Porta FA; Burgio GR
Eur J Pediatr; 1989 Jan; 148(4):379-80. PubMed ID: 2707286
[No Abstract] [Full Text] [Related]
4. Biotherapy of chronic myelogenous leukemia with interferon.
Ozer H
Semin Oncol; 1988 Oct; 15(5 Suppl 5):14-20. PubMed ID: 2461592
[No Abstract] [Full Text] [Related]
5. Anti-interferon antibodies in alpha interferon treated patients with chronic myeloid leukaemia.
Aitchison R; Allen P; Schey S; Newland AC
Br J Haematol; 1991 Jul; 78(3):465-7. PubMed ID: 1873235
[No Abstract] [Full Text] [Related]
6. Activity of alpha-interferons in chronic myelogenous leukaemia.
Talpaz M
Br J Clin Pract Suppl; 1988 Mar; 62():13-5. PubMed ID: 3145008
[No Abstract] [Full Text] [Related]
7. Therapy with recombinant interferon alpha-2c during unexpected pregnancy in a patient with chronic myeloid leukaemia.
Reichel RP; Linkesch W; Schetitska D
Br J Haematol; 1992 Oct; 82(2):472-3. PubMed ID: 1419831
[No Abstract] [Full Text] [Related]
8. [Interferon and chronic myeloid leukemia].
Steegmann JL; Pérez Sánchez M; Fernández-Rañada JM
Sangre (Barc); 1990 Jun; 35(3):213-7. PubMed ID: 2204124
[No Abstract] [Full Text] [Related]
9. Pregnancy during myelosuppressive treatment for chronic myelogenous leukemia.
Delmer A; Rio B; Bauduer F; Ajchenbaum F; Marie JP; Zittoun R
Br J Haematol; 1992 Dec; 82(4):783-4. PubMed ID: 1482675
[No Abstract] [Full Text] [Related]
10. Clinical studies with interferons in Philadelphia positive chronic myelogenous leukemia.
Talpaz M; Kantarjian H; Kurzrock R; Gutterman JU
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():63. PubMed ID: 2496883
[No Abstract] [Full Text] [Related]
11. CML: new biologic therapies, endpoints and questions.
Martin A; Cheson BD
Oncology (Williston Park); 1987 Sep; 1(7):12-3, 16. PubMed ID: 3152809
[No Abstract] [Full Text] [Related]
12. Predicting complete cytogenetic response in chronic myelogenous leukemia patients treated with recombinant interferon alpha.
Mahon FX; Montastruc M; Faberes C; Reiffers J
Blood; 1994 Nov; 84(10):3592-4. PubMed ID: 7832859
[No Abstract] [Full Text] [Related]
13. Elimination by interferon-alpha of malignant clone in chronic myeloid leukaemia.
Opalka B; Kloke O; Bartram CR; Beer U; Janssen JW; Niederle N; Wandl UB
Lancet; 1989 Jun; 1(8650):1334. PubMed ID: 2566865
[No Abstract] [Full Text] [Related]
14. [Therapy of chronic myeloid leukemia with interferon].
Fülle HH; Dahmen E; Hellriegel KP
Onkologie; 1988 Aug; 11(4):177-83. PubMed ID: 3054669
[TBL] [Abstract][Full Text] [Related]
15. [A case of chronic myeloid leukemia with cytogenetic remission and disappearance of Ph1 positive cells due to interferon-alpha administration].
Yoshida M; Fujiwara Y; Yoshinaga H; Maeda T; Mori Y; Nonaka K; Senoo K; Atsui F
Nihon Naika Gakkai Zasshi; 1991 May; 80(5):766-7. PubMed ID: 1875114
[No Abstract] [Full Text] [Related]
16. Low-dose interferon-alpha in Ph+ chronic myeloid leukemia: clinical cytogenetic and cell culture study.
Russo D; Zuffa E; Motta MR; Santucci MA; Fanin R; Testoni N; Celso B; Visani G; Baccarani M; Tura S
Haematologica; 1988; 73(6):499-502. PubMed ID: 3148512
[No Abstract] [Full Text] [Related]
17. Interferon in CML.
Br J Hosp Med; 1988 Jul; 40(1):77. PubMed ID: 3167297
[No Abstract] [Full Text] [Related]
18. [The treatment of chronic myeloleukemia with recombinant alfa-2 interferon].
Strozha I; Petukhov V; Bondare D; Feldmane G; Duks A; Teilane I; Medne I; Mauritsas M; Grinberga L
Ter Arkh; 1993; 65(10):62-6. PubMed ID: 8296238
[TBL] [Abstract][Full Text] [Related]
19. Interferon alpha-2a to control thrombocytosis in chronic myelogenous leukemia and essential thrombocythemia.
Jootar S
Asian Pac J Allergy Immunol; 1989 Dec; 7(2):103-5. PubMed ID: 2624663
[TBL] [Abstract][Full Text] [Related]
20. Chronic myelogenous leukemia: an overview.
Bergsagel DE
J Cancer Res Clin Oncol; 1990; 116(1):104-5. PubMed ID: 2312599
[No Abstract] [Full Text] [Related]
[Next] [New Search]
